Previous 10 | Next 10 |
2023-10-30 17:32:19 ET More on PURE Bioscience Financial information for PURE Bioscience For further details see: PURE Bioscience GAAP EPS of -$0.04, revenue of $1.87M
Update on Business and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial...
FNCB Bancorp Inc. (FNCB) is expected to report for Q1 2024 Civista Bancshares Inc. (CIVB) is expected to report $0.6 for Q3 2023 ASLAN Pharmaceuticals Limited (ASLN) is expected to report $-0.85 for Q3 2023 Grupo Televisa S.A. (TV) is expected to report $0.02 for Q3 2023 Red River...
Pure Bioscience Inc (PURE) is expected to report for quarter end 2023-07-31
July 16 th -19 th , 2023, Toronto, Ontario, Canada Booth #530 PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, is set to unveil its “PURE Genius” food safety program at the 2023 Intern...
2023-06-14 16:22:22 ET PURE Bioscience press release ( OTC:PURE ): Q3 GAAP EPS of -$0.01. Revenue of $0.41M (-18.0% Y/Y). For further details see: PURE Bioscience GAAP EPS of -$0.01, revenue of $0.41M
Update on Business Segments and PURE’s SDC-Based Antimicrobial Solutions PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal third quarter and nine-month ...
2023-03-20 01:26:07 ET PURE Bioscience press release ( OTC:PURE ): FQ2 GAAP EPS of -$0.01. Revenue of $0.4M (-4.8% Y/Y). For further details see: PURE Bioscience GAAP EPS of -$0.01, revenue of $0.4M
PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period ended January 31, 2023. Q2: Summary of Results of Operations Net prod...
Update on Business and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial...
News, Short Squeeze, Breakout and More Instantly...
PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported the appointment of Darin Zehr to its Board of Directors, effective as of May 1...
Update on Business and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial...